A draft policy from the US National Institutes of Health says that multi-site clinical studies should use a single institutional review board, according to an agency press release.

When protections for research participants were established, NIH notes that most studies were conducted at one site. Now as many studies are taking place across a number of sites, multiple IRBs are used. This, the agency argues, is not efficient.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.